Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role

Domenico Mercurio(Mario Negri Institute for Pharmacological Research), Maria Grazia De Simoni(Istituto di Fisiologia Clinica), Wilhelm Schwaeble(University of Cambridge), Nicholas J. Lynch(Mario Negri Institute for Pharmacological Research), Russell Wallis(University of Leeds), Silke Roscher(University of Leicester), Stefano Fumagalli(Mario Negri Institute for Pharmacological Research), Stefania Ippati(Mario Negri Institute for Pharmacological Research), Denise Minuta(Vita-Salute San Raffaele University), Marco Oggioni(Mario Negri Institute for Pharmacological Research), Carlo Perego(Mario Negri Institute for Pharmacological Research)
Acta Neuropathologica Communications
October 28, 2020
Cited by 26


Related Papers